Elkhuizen PHM - Search Results

1

De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.

de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: elkhuizen phm. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707

2

Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03).

Boersma LJ, Verloop J, Voogd AC, Elkhuizen PHM, Houben R, van Leeuwen AE, Linn S, de Munck L, Pijnappel R, Strobbe L, van Dalen T, Wesseling J, Poortmans P. Boersma LJ, et al. Among authors: elkhuizen phm. Radiother Oncol. 2020 Apr;145:201-208. doi: 10.1016/j.radonc.2020.01.018. Epub 2020 Feb 10. Radiother Oncol. 2020. PMID: 32058873

3

Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial.

van Werkhoven E, Hart G, Tinteren Hv, Elkhuizen P, Collette L, Poortmans P, Bartelink H. van Werkhoven E, et al. Radiother Oncol. 2011 Jul;100(1):101-7. doi: 10.1016/j.radonc.2011.07.004. Epub 2011 Aug 5. Radiother Oncol. 2011. PMID: 21821304 Clinical Trial.

4

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.

Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan D, Dubois JB, Remouchamps V, Mirimanoff RO, Collette S, Collette L; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Bartelink H, et al. Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9. Lancet Oncol. 2015. PMID: 25500422 Clinical Trial.

5

A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients.

Bosma SCJ, Hoogstraat M, van Werkhoven E, de Maaker M, van der Leij F, Elkhuizen PHM, Fourquet A, Poortmans P, Boersma LJ, Bartelink H, van de Vijver MJ; Young Boost Trial research group. Bosma SCJ, et al. Among authors: elkhuizen phm. Radiother Oncol. 2021 Mar;156:127-135. doi: 10.1016/j.radonc.2020.11.025. Epub 2020 Nov 24. Radiother Oncol. 2021. PMID: 33245949 Clinical Trial.

6

Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.

Bosma SC, van der Leij F, van Werkhoven E, Bartelink H, Wesseling J, Linn S, Rutgers EJ, van de Vijver MJ, Elkhuizen PH. Bosma SC, et al. Breast Cancer Res Treat. 2016 Apr;156(2):391-400. doi: 10.1007/s10549-016-3732-0. Epub 2016 Mar 23. Breast Cancer Res Treat. 2016. PMID: 27008183

7

Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines.

Boersma LJ, Janssen T, Elkhuizen PH, Poortmans P, van der Sangen M, Scholten AN, Hanbeukers B, Duppen JC, Hurkmans C, van Vliet C. Boersma LJ, et al. Radiother Oncol. 2012 May;103(2):178-82. doi: 10.1016/j.radonc.2011.12.021. Epub 2012 Jan 20. Radiother Oncol. 2012. PMID: 22265730

8

Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation.

van der Leij F, Elkhuizen PH, Janssen TM, Poortmans P, van der Sangen M, Scholten AN, van Vliet-Vroegindeweij C, Boersma LJ. van der Leij F, et al. Radiother Oncol. 2014 Mar;110(3):467-70. doi: 10.1016/j.radonc.2013.10.033. Epub 2013 Nov 18. Radiother Oncol. 2014. PMID: 24262820

9

Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute.

van der Leij F, van Werkhoven E, Bosma S, Linn SC, Rutgers EJ, van de Vijver MJ, Bartelink H, Elkhuizen PHM, Scholten A. van der Leij F, et al. Among authors: elkhuizen phm. Breast. 2016 Dec;30:19-25. doi: 10.1016/j.breast.2016.08.004. Epub 2016 Aug 29. Breast. 2016. PMID: 27587341

10

Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer Patients.

Bosma SCJ, Hoogstraat M, van der Leij F, de Maaker M, Wesseling J, Lips E, Loo CE, Rutgers EJ, Elkhuizen PHM, Bartelink H, van de Vijver MJ. Bosma SCJ, et al. Among authors: elkhuizen phm. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):174-181. doi: 10.1016/j.ijrobp.2019.09.002. Epub 2019 Sep 13. Int J Radiat Oncol Biol Phys. 2020. PMID: 31525407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page